AssetMark Inc’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.9M Buy
232,295
+57,422
+33% +$6.63M 0.06% 263
2025
Q4
$18.4M Sell
174,873
-2,045
-1% -$192K 0.04% 344
2025
Q3
$14.8M Buy
176,918
+22,483
+15% +$1.85M 0.03% 363
2025
Q2
$12.2M Sell
154,435
-3,278
-2% -$261K 0.03% 373
2025
Q1
$14.2M Sell
157,713
-9,182
-6% -$857K 0.04% 304
2024
Q4
$16.6M Buy
166,895
+19,719
+13% +$2.03M 0.05% 278
2024
Q3
$16.7M Buy
147,176
+16,911
+13% +$2.01M 0.05% 258
2024
Q2
$16.1M Buy
130,265
+14,495
+13% +$1.87M 0.05% 251
2024
Q1
$15.3M Buy
115,770
+11,935
+11% +$1.47M 0.05% 240
2023
Q4
$11.3M Sell
103,835
-4,208
-4% -$437K 0.04% 251
2023
Q3
$11.1M Buy
108,043
+3,284
+3% +$354K 0.04% 244
2023
Q2
$12.1M Buy
104,759
+23,677
+29% +$2.69M 0.05% 233
2023
Q1
$8.63M Buy
81,082
+4,806
+6% +$519K 0.04% 256
2022
Q4
$8.46M Buy
76,276
+8,476
+13% +$866K 0.04% 242
2022
Q3
$5.84M Buy
67,800
+6,281
+10% +$561K 0.03% 257
2022
Q2
$5.61M Buy
61,519
+33,541
+120% +$2.97M 0.03% 252
2022
Q1
$2.3M Buy
27,978
+6,882
+33% +$543K 0.01% 326
2021
Q4
$1.62M Sell
21,096
-334,748
-94% -$26.7M 0.01% 354
2021
Q3
$26.7M Buy
355,844
+11,402
+3% +$867K 0.12% 160
2021
Q2
$26.8M Sell
344,442
-192,226
-36% -$14.3M 0.12% 162
2021
Q1
$39.5M Sell
536,668
-441,568
-45% -$32.6M 0.2% 118
2020
Q4
$76.4M Buy
978,236
+118,829
+14% +$9.09M 0.43% 66
2020
Q3
$68M Buy
859,407
+90,851
+12% +$7.12M 0.44% 64
2020
Q2
$57.3M Buy
768,556
+147,648
+24% +$11.1M 0.41% 62
2020
Q1
$45.6M Buy
620,908
+553,451
+820% +$43.5M 0.39% 69
2019
Q4
$5.85M Buy
67,457
+54,646
+427% +$4.49M 0.04% 240
2019
Q3
$1.03M Buy
12,811
+1,091
+9% +$87.4K 0.01% 312
2019
Q2
$938K Buy
11,720
+2,847
+32% +$218K 0.01% 303
2019
Q1
$704K Buy
8,873
+357
+4% +$26.7K 0.01% 314
2018
Q4
$621K Buy
8,516
+934
+12% +$65.9K 0.01% 318
2018
Q3
$513K Sell
7,582
-227
-3% -$14.5K ﹤0.01% 347
2018
Q2
$452K Sell
7,809
-414
-5% -$23.4K ﹤0.01% 361
2018
Q1
$427K Sell
8,223
-18,929
-70% -$1.02M ﹤0.01% 357
2017
Q4
$1.46M Sell
27,152
-8,436
-24% -$468K 0.02% 272
2017
Q3
$2.17M Sell
35,588
-7,686
-18% -$466K 0.02% 246
2017
Q2
$2.65M Buy
43,274
+3,236
+8% +$197K 0.03% 231
2017
Q1
$2.43M Sell
40,038
-2,781
-6% -$169K 0.03% 232
2016
Q4
$2.4M Buy
42,819
+17,770
+71% +$1.04M 0.04% 211
2016
Q3
$1.49M Sell
25,049
-3,988
-14% -$233K 0.02% 232
2016
Q2
$1.6M Buy
29,037
+11,564
+66% +$615K 0.03% 231
2016
Q1
$882K Buy
17,473
+1,983
+13% +$97.1K 0.02% 277
2015
Q4
$781K Buy
15,490
+14,736
+1,954% +$743K 0.01% 314
2015
Q3
$36K Buy
754
+609
+420% +$32.4K ﹤0.01% 407
2015
Q2
$8K Buy
+145
New +$8.13K ﹤0.01% 543
2014
Q3
Sell
-1
Closed 497
2014
Q2
$0 Sell
1
-52,137
-100% -$2.84M ﹤0.01% 507
2014
Q1
$2.82M Sell
52,138
-6,088
-10% -$315K 0.07% 120
2013
Q4
$2.78M Buy
+58,226
New +$2.66M 0.07% 139

Other funds holding MRK

AssetMark Inc's MRK Position: Q1 2026 in Review

AssetMark Inc increased its Merck (MRK) stake by 33% in Q1 2026, buying an estimated $6.63M and bringing the position to 232,295 shares worth $27.9M. The position accounts for 0.06% of the portfolio, ranked #263.

AssetMark Inc first reported a position in MRK in Q4 2013 and has held it in 47 quarters since. The position peaked at $76.4M in Q4 2020. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • AssetMark Inc held 232,295 shares of Merck worth $27.9M as of Q1 2026.
  • AssetMark Inc bought 57,422 Merck shares in Q1 2026, an estimated $6.63M.
  • Merck made up 0.06% of AssetMark Inc's portfolio in Q1 2026, its #263 holding.
  • AssetMark Inc first reported a position in Merck in Q4 2013 and has held it in 47 quarters since.
  • AssetMark Inc's Merck position peaked at $76.4M in Q4 2020.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.